Clinical and non-clinical evaluation during the consultation procedure on medicinal substances contained in drug-eluting (medicinal-substance-eluting) coronary stents - Scientific guideline

This document addresses the clinical and non-clinical aspects of the evaluation of ancillary medicinal substances contained in a drug-eluting coronary stents.

Keywords: Drug eluting stents, non-clinical safety, clinical safety

Current effective version

Guideline on clinical and non-clinical evaluation during the consultation procedure on medicinal substances contained in drug-eluting (medicinal substance-eluting) coronary stents

AdoptedReference Number: EMEA/CHMP/EWP/110540/2007Legal effective date: 01/12/2008

Document history

Overview of comments received on draft guideline on the development medicinal substances contained in drug-eluting (medicinal substance-eluting) coronary stents

Reference Number: EMEA/CHMP/EWP/242067/2008

Draft guideline on the development medicinal substances contained in drug-eluting (medicinal substance-eluting) coronary stents

Draft: consultation closedReference Number: EMEA/CHMP/EWP/110540/2007

Concept paper on the development of a CHMP guideline on the evaluation of non-clinical and clinical data on the medicinal substances contained in drug-eluting (medicinal substance-eluting) coronary stents within the fram...

Reference Number: EMEA/CHMP/EWP/56477/2006